Feature Channels:

Cell Biology

Add to Favorites Subscribe Share
fbshare-Cell Biology

Showing results

110 of 6816
Embargo will expire:
25-Jul-2019 11:00 AM EDT
Released to reporters:
23-Jul-2019 1:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: First Impressions Go a Long Way in the Immune System

Article ID: 716260

First Impressions Go a Long Way in the Immune System

Weizmann Institute of Science

When immune cells and bacteria meet, the outcome is decided fairly quickly – including whether the bacteria will lie dormant, as in diseases like tuberculosis. Now, Weizmann Institute scientists have developed an algorithm that predicts how the immune system will respond to a pathogen, thus leading to early diagnosis for infectious diseases.

Released:
23-Jul-2019 12:05 PM EDT

Article ID: 716216

Mount Sinai Researchers Develop Novel Vaccine That Induces Antibodies that Contribute to Protection from HIV Infection

Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel vaccine consisting of DNA and recombinant proteins⸺proteins composed of a portion of an HIV protein and another unrelated protein.

Released:
23-Jul-2019 11:00 AM EDT

Article ID: 716228

Privatization of public goods can cause population decline, research shows

University of Exeter

Scientists have given a fascinating new insight into the way microbes adopt a 'co-operative' approach to securing the nutrients they need to thrive.

Released:
23-Jul-2019 10:05 AM EDT
mmc-logo.gif

Article ID: 716210

Terapia com célula tronco avança pesquisa para crianças com síndrome da hipoplasia do coração esquerdo

Mayo Clinic

Um estudo clínico de fase 1 é a primeira pesquisa monitorada pela Food and Drug Administration (Agência Americana de Controle de Alimentos e Medicamentos) que demonstra o potencial da terapia regenerativa para a síndrome da hipoplasia do coração esquerdo (SHCE) por meio de coleta, processamento e introdução das próprias células tronco da criança no coração durante o momento da cirurgia.

Released:
23-Jul-2019 9:00 AM EDT
Newswise: To Assess a Cell’s Health, Follow the Glucose

Article ID: 716209

To Assess a Cell’s Health, Follow the Glucose

National Institute of Biomedical Imaging and Bioengineering

A new spectroscopic technique reveals that glucose use in live cells provides valuable information about the functional status of cells, tissues, and organs. Shifts in a cell’s use of glucose can signal changes in health and progress of disease.

Released:
23-Jul-2019 9:00 AM EDT
Newswise: Learning to Look

Article ID: 716180

Learning to Look

Lawrence Berkeley National Laboratory

Inoviruses are filamentous viruses with small, single-stranded DNA genomes. Applying machine learning to more than 70,000 microbial and metagenome datasets, a team led by JGI scientists identified more than 10,000 inovirus-like sequences compared to the 56 previously known inovirus genomes.

Released:
22-Jul-2019 3:45 PM EDT
Newswise: August’s SLAS Technology Issue Now Available

Article ID: 716158

August’s SLAS Technology Issue Now Available

SLAS (Society for Laboratory Automation and Screening)

The August edition of SLAS Technology features the cover article, “Technologies for the Directed Evolution of Cell Therapies,” a review featured in the journal’s March 2019 edition. The research, led by Dino Di Carlo, Ph.D., (University of California Los Angeles) highlights how the next generation of therapies are moving beyond the use of small molecules and proteins to using whole cells.

Released:
22-Jul-2019 12:05 PM EDT
Newswise: Scientists develop promising drug for treating ovarian and pancreatic cancers
  • Embargo expired:
    22-Jul-2019 10:00 AM EDT

Article ID: 716103

Scientists develop promising drug for treating ovarian and pancreatic cancers

Houston Methodist

Known as two of the most lethal cancers, ovarian and pancreatic cancer are often called silent killers. As a result, they frequently go undetected until they’re too late to effectively treat. Cancer scientists at Houston Methodist have been vigilant about looking for more effective late-stage treatments and may have found one.

Released:
19-Jul-2019 2:05 PM EDT
Newswise: Common Feature of Cancer Cells That Makes Them Appear Overstuffed May Also Be Their Achilles’ Heel

Article ID: 716097

Common Feature of Cancer Cells That Makes Them Appear Overstuffed May Also Be Their Achilles’ Heel

Johns Hopkins Medicine

In a study using yeast cells and data from cancer cell lines, Johns Hopkins University scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes, the structures that carry genetic material. The vulnerability, they say, is rooted in a common feature among cancer cells — their high intracellular protein concentrations — that make them appear bloated and overstuffed, and which could be used as possible new targets for cancer treatments.

Released:
22-Jul-2019 9:00 AM EDT

Showing results

110 of 6816

Chat now!